Navigation

Overactive bladder - mirabegron [ID542]

Mirabegron for the treatment of symptoms associated with overactive bladder

Status: History
Expected date of issue: June 2013
Referral date: July 2012
Process: STA
Notes:

Scoped as part of Batch 23

Topic area:
  • Urogenital
 

NICE project team

Executive Lead: TBC
Technical Lead: Grace Jennings
Communications manager: Paul Cooney
Project manager: Bijal Joshi
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 24 October 2012
1st appraisal committee meeting: 06 February 2013
2nd appraisal committee meeting 09 April 2013
Top


 

Consultees and commentators

To be confirmed

Top


 

Key documents

This page was last updated: 02 July 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.